Skip to main content
Log in

Omega-3-acid ethyl ester medicines: risk of AF in patients with established CV diseases or CV risk factors

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omega-3-acid ethyl ester medicines: risk of AF in patients with established CV diseases or CV risk factors. Reactions Weekly 1983, 3 (2023). https://doi.org/10.1007/s40278-023-49352-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-49352-x

Navigation